This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, Marburg virus disease, cholera, avian influenza, bacillus in infant formula, and nipah virus disease.
Respiratory virus circulation is elevated across the EU/EEA: the circulation of influenza viruses remains high with early signs of a new increase, RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
This Single Programming Document 2026–2028 sets the course for a science-driven independent modern, agile, and science-driven ECDC – one that is ready to anticipate and respond to future health threats, and foster smart collaboration to safeguard the health of Europe’s citizens. Now more than ever, Europe needs to rely on its own strength and scientific capacities – we can only do this together.
ECDC, Africa CDC and the WHO Regional Office for Africa are conducting training in R programming and epidemic intelligence for surveillance experts from the National Public Health Agency of Sierra Leone.
The purpose of this policy is to lay down the rules for reimbursement of expenses that have been incurred by invitees who were invited by ECDC (the Centre) to a meeting/event/activity or similar.
